EGFR and cancer: This promotes MEK1/2 followed by the activation of ERK1/2 which regulates different transcription factors, modulating gene expression.468 In cancers, this pathway can be activated by cytokine mutations, overexpression of wild/mutant receptors (e.g., EGFR).